ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
Anticancer drugs often have widespread effects on the cellular proteome. Here, the authors generate a proteome signature library of drug-treated cancer cell lines and develop a software tool to deconvolute drug targets and gain insights into their mechanisms of action.
Guardado en:
Autores principales: | Amir Ata Saei, Christian Michel Beusch, Alexey Chernobrovkin, Pierre Sabatier, Bo Zhang, Ülkü Güler Tokat, Eleni Stergiou, Massimiliano Gaetani, Ákos Végvári, Roman A. Zubarev |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad0814e6df26497b89b780d2b504f842 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
System-wide identification and prioritization of enzyme substrates by thermal analysis
por: Amir Ata Saei, et al.
Publicado: (2021) -
Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins.
por: Alexey L Chernobrovkin, et al.
Publicado: (2014) -
Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin
por: Pierre Sabatier, et al.
Publicado: (2021) -
An integrative proteomics method identifies a regulator of translation during stem cell maintenance and differentiation
por: Pierre Sabatier, et al.
Publicado: (2021) -
Expression proteomics study to determine metallodrug targets and optimal drug combinations
por: Ronald F. S. Lee, et al.
Publicado: (2017)